For Oncology Nurses: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from the 2026 Annual ONS Congress - Prostate Cancer Update

Om avsnittet

Featuring perspectives from Dr Alexandra Drakaki, Ms Krisztina Emodi, Dr Terence Friedlander and Ms Margarita Huober, moderated by Dr Friedlander, including the following topics:

Introduction: Basic Biology of Nonmetastatic Urothelial Bladder Cancer (UBC) (0:00)
Systemic Therapy for Cisplatin-Eligible Patients with Muscle-Invasive Bladder Cancer (MIBC) (13:35)
Evolving Approach to Systemic Therapy for Cisplatin-Ineligible Patients with MIBC (37:13)
Immune Checkpoint Inhibitors in Non-Muscle-Invasive Bladder Cancer (58:55)
Novel Intravesical Therapies for Nonmetastatic UBC (1:10:20)

NCPD information and select publications

For Oncology Nurses: Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Proceedings from the 2026 Annual ONS Congress

Om avsnittet

Fler avsnitt

Prostate Cancer with PTEN Deficiency — An Interview with Dr Neeraj Agarwal

Metastatic Bladder Cancer — Rapid Case Review Issue 8

Metastatic Bladder Cancer — Rapid Case Review Issue 7

Prostate Cancer — The Optimal Use of Hormonal Therapy

AKT Inhibition in Prostate Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

For Oncology Nurses: Prostate Cancer — Proceedings from the 2026 Annual ONS Congress

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 4: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

Non-Muscle-Invasive and Muscle-Invasive Bladder Cancer — Microlearning Activity 3: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

AKT Inhibition in Prostate Cancer — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium

AKT Inhibition in Prostate Cancer — Microlearning Activity 1: Proceedings from a Session Held Adjunct to the 2026 ASCO GU Cancers Symposium